help button home button JAMIA Bigger figures
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

First published June 7, 2004 as JAMIA PrePrint; doi:10.1197/jamia.M1296
Journal of the American Medical Informatics Association 2004;11(5):427-432
© 2004 American Medical Informatics Association


A more recent version of this article appeared on September 1, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M1296v1
11/5/427    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martin, P.
Right arrow Articles by Martin-Facklam, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martin, P.
Right arrow Articles by Martin-Facklam, M.

Submitted on November 25, 2002
Accepted on May 15, 2004

A drug database model as a central element for computer-supported dose adjustment within a CPOE system

Peter Martin BSc1, Walter E. Haefeli MD1, and Meret Martin-Facklam PhD1*

Affiliation of the authors: 1 Department of Internal Medicine VI, Clinical Pharmacology and Pharmacoepidemiology, Ruprecht-Karls-University, Heidelberg, Germany

* To whom correspondence should be addressed.

The incidence of adverse drug reactions may be decreased by computerised physician order entry (CPOE) with decision support. We describe the development of a drug database model for computer-supported dose adjustment within a CPOE system. The following two core elements were included: 1) In order to allow electronic dose and volume calculation the relation between strength (e.g. 5 mg / 1 mL) and prescribed unit (e.g. 1 ampoule containing 2 ml) must be available in coded form. 2) The site of action along with the parent active ingredient, i.e. the pure drug without salt or ester, is necessary for linkage to knowledge bases. All complex examples of drugs we examined could be described by the data model. With the ultimate goal of increasing prescribing effectiveness and quality we developed a drug database model for inclusion in a CPOE system, which allows dose calculations and may be coupled to decision support systems.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 1994 by the American Medical Informatics Association.